Each lot is tested by HPLC for purity, LC-MS for identity confirmation, and endotoxin assay for sterility readiness
FDABPC-157 and related peptides are not FDA-approved drugs
The question: does sustained elevation of intracellular NAD+ via NNMT inhibition produce the same long-term benefits as NAD+ precursor supplementation (like nicotinamide riboside or NMN), or are there trade-offs we haven't identified yet
Disclaimer: Peptide therapies are not FDA-approved to diagnose, treat, cure, or prevent any disease
Many clients choose it for metabolism and weight-loss support, especially when paired with nutrition, movement, and a broader wellness plan
These lipids were not derived from a single PDB entry but were built using the standard chemical definitions within the CHARMM-GUI Membrane Builder